Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Sprayable Powder-Type Hemostatic Agent Stops Bleeding in One Second

By HospiMedica International staff writers
Posted on 12 Jan 2026

Uncontrolled bleeding remains the leading cause of preventable death from injuries. More...

Rapid blood loss can be fatal within minutes, especially when wounds are deep, irregular, or difficult to compress. Existing hemostatic patches are often ineffective in such scenarios and can be impractical in harsh environments. New research now presents a spray-on powder that can stop bleeding within one second, offering a potential breakthrough for emergency care, especially in medically underserved areas.

An interdisciplinary team of researchers at the Korea Advanced Institute of Science and Technology (Daejeon, South Korea) has designed a powder-type hemostatic agent optimized for emergency medicine. The agent rapidly transforms into a strong hydrogel barrier upon contact with blood, enabling immediate wound sealing without complex preparation.

The researchers focused on overcoming the limitations of flat, patch-based hemostatic products by creating a free-flowing powder suitable for deep and irregular wounds. The formulation, known as AGCL powder, combines naturally derived materials including alginate and gellan gum, which undergo ultra-fast gelation in the presence of calcium ions, and chitosan, which enhances biological clotting through interaction with blood components. The powder’s internal three-dimensional structure was engineered to maximize blood absorption and adhesion.

The AGCL powder gelled within approximately one second after application and absorbed more than seven times its own weight in blood. It demonstrated strong sealing performance under high-pressure bleeding, with adhesive strength exceeding 40 kPa, outperforming commercial hemostatic agents. Safety testing showed low hemolysis, high cell viability, and strong antibacterial activity. In animal models, the powder reduced bleeding time, promoted tissue regeneration, and supported normal organ recovery without systemic toxicity.

The hemostatic agent maintained performance for up to two years under room temperature and high-humidity conditions, making it suitable for storage and rapid deployment in resource-limited settings. The technology could be used widely in emergency medicine, trauma care, and humanitarian response, where rapid bleeding control is critical.

Related Links:
KAIST


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.